Establishment Labs (ESTA) vs Viemed Healthcare (VMD)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 10, 2026.
Summary
Establishment Labs (ESTA) has outperformed Viemed Healthcare (VMD) over the past year, gaining 53.7% versus a gain of 38.6%. Over five years, VMD leads with a +65.0% price change compared with -19.9% for ESTA. Establishment Labs is the larger company by market cap ($1.84 billion vs $362.6 million), about 5.1 times the size.
On valuation, Viemed Healthcare trades at a lower forward P/E (23.8x vs 1027.8x for Establishment Labs).
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ESTA | VMD |
|---|---|---|
| Share price | $61.67 | $9.52 |
| Market cap | $1.84B | $362.60M |
| 1-day change | +1.75% | +1.17% |
| YTD return | -15.38% | +28.13% |
| 1-year return | +53.71% | +38.57% |
| 5-year return | -19.91% | +64.99% |
| P/E ratio (TTM) | — | 26.44 |
| Forward P/E | — | 23.80 |
| EPS (TTM) | $-1.30 | $0.36 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $211.08M | — |
| Revenue growth (YoY) | +27.14% | — |
| Net income (latest FY) | $-51.06M | — |
| Gross margin | 69.32% | — |
| Operating margin | -18.48% | — |
| Net margin | -24.19% | — |
| 52-week high | $97.59 | $12.61 |
| 52-week low | $38.55 | $6.05 |
| Distance from 52-week high | -36.81% | -24.50% |
| Analyst consensus | strong_buy | buy |
| Avg. price target upside | +66.11% | +31.30% |
| Average volume | 427.57K | 353.27K |
| Shares outstanding | 29.80M | 38.09M |
| Employees | 1,004 | 1,438 |
| Sector | Health Care | Health Care |
| Industry | Industrial Specialties | Misc Health and Biotechnology Services |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Establishment Labs is about 5.1 times larger than Viemed Healthcare by market value ($1.84B vs $362.60M).
- ESTA has outperformed VMD by 15.1 percentage points over the past year.
About Establishment Labs
ESTA stock →Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for breast aesthetic and reconstructive plastic surgeries in Europe, the Middle East, Africa, Latin America, Asia, and the United States. The company offers silicone gel-filled breast implants under the Motiva Implants brand.
Health Care · Industrial Specialties · 1,004 employees
About Viemed Healthcare
VMD stock →Viemed Healthcare, Inc., through its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services in the United States. The company provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD.
Health Care · Misc Health and Biotechnology Services · 1,438 employees
ESTA vs VMD FAQ
Which is bigger, Establishment Labs or Viemed Healthcare?
Establishment Labs (ESTA) is larger, with a market capitalization of $1.84B compared with $362.60M for Viemed Healthcare (VMD).
Which stock has performed better over the past year, ESTA or VMD?
ESTA returned +53.71% over the past 12 months, compared with +38.57% for VMD (price return, excluding dividends). Past performance does not predict future results.
Are Establishment Labs and Viemed Healthcare in the same industry?
Both are in the Health Care sector, but in different industries: Industrial Specialties for Establishment Labs and Misc Health and Biotechnology Services for Viemed Healthcare.